The latest price target for Mesa Laboratories (NASDAQ:MLAB) was reported by Wells Fargo on December 15, 2025. The analyst firm set a price target for $83.00 expecting MLAB to rise to within 12 months (a possible 6.64% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Mesa Laboratories (NASDAQ:MLAB) was provided by Wells Fargo, and Mesa Laboratories maintained their equal-weight rating.

The last upgrade for Mesa Laboratories Inc happened on August 8, 2025 when Wells Fargo raised their price target to $67. Wells Fargo previously had an underweight for Mesa Laboratories Inc.

There is no last downgrade for Mesa Laboratories.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesa Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesa Laboratories was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.

While ratings are subjective and will change, the latest Mesa Laboratories (MLAB) rating was a maintained with a price target of $75.00 to $83.00. The current price Mesa Laboratories (MLAB) is trading at is $77.83, which is within the analyst’s predicted range.